Literature DB >> 742493

Development of the IgA system in the mammary gland.

M E Lamm, P Weisz-Carrington, M E Roux, M McWilliams, J M Phillips-Quagliata.   

Abstract

1) Lymphoblasts in gut-associated lymphoid tissue, committed to the production of IgA, can home to the mammary glands of syngeneic mice and differentiate there into IgA-containing plasmablasts. The phenomenon is limited to near term and lactating recipients. 2) The ability of lymphocytes originating in gut-associated lymphoid tissue and sensitized to intestinal antigens to migrate to the mammary gland can account for the specificity of milk IgA toward intestinal microorganisms and the consequent passive protection offered to suckling infants. 3) The secretory immune system of the mammary gland is apparently under hormonal control since mammotropic hormones given to virgin females can induce morphological and functional characteristics seen naturally only during pregnancy and lactation. Examples are increased numbers of IgA plasma cells and the ability to trap their circulating precursors taken from mesenteric lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 742493     DOI: 10.1007/978-1-4684-3369-2_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  Antibodies in milk.

Authors:  E Telemo; L A Hanson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  IgA ASC accumulation to the lactating mammary gland is dependent on VCAM-1 and alpha4 integrins.

Authors:  Elizabeth N Low; Lauren Zagieboylo; Benjamin Martino; Eric Wilson
Journal:  Mol Immunol       Date:  2010-02-19       Impact factor: 4.407

3.  Distribution of immunoglobulin-containing cells in normal and neonatally thymectomized rats.

Authors:  J L Ebersole; M A Taubman; D J Smith
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

4.  Antibacterial and antitoxin responses in the serum and milk of cholera patients.

Authors:  A S Majumdar; P Dutta; D Dutta; A C Ghose
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.